Silexion Therapeutics (SLXN) EBT (2023 - 2026)
Silexion Therapeutics (SLXN) posted quarterly EBT of -$2.7 million for Q1 2026, down 57.52% year-over-year from -$6.4 million in Q1 2025, and up 38.06% quarter-over-quarter from -$4.4 million in Q4 2025.
Silexion Therapeutics (SLXN) EBT (2023 - 2026) Analysis & Trends
Silexion Therapeutics' EBT history runs 4 years deep, the most recent figure standing at -$2.7 million for Q1 2026.
- In Q1 2026, EBT fell 57.52% year-over-year to -$2.7 million; the TTM figure through Mar 2026 stood at -$12.9 million (up 23.29% YoY), while the FY2025 annual figure was -$11.9 million, up 27.86% from the prior year.
- EBT for Q1 2026 stood at -$2.7 million, up from -$4.4 million in the prior quarter.
- The five-year high for EBT was -$803000.0 in Q3 2023, with the low at -$11.9 million in Q3 2024.
- The 4-year median for EBT is -$1.8 million (2023), against an average of -$3.0 million.
- The sharpest annual moves came in 2024 and 2025: EBT tumbled 1376.71% in 2024, then jumped 72.49% in 2025.
- Silexion Therapeutics' EBT stood at -$1.7 million in 2023, then slipped by 4.3% to -$1.7 million in 2024, then tumbled by 152.69% to -$4.4 million in 2025, then soared by 38.06% to -$2.7 million in 2026.
- Business Quant data shows SLXN's EBT at -$2.7 million in Q1 2026, -$4.4 million in Q4 2025, and -$3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - | 81.49 Mn |
| 10 | Silexion Therapeutics | 268,273.88 | -1.96 Mn | - | -3.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.55 Mn |
| Mar 31, 2026 | -2.73 Mn |
| Dec 31, 2025 | -4.41 Mn |
| Sep 30, 2025 | -3.26 Mn |
| Jun 30, 2025 | -2.50 Mn |
| Mar 31, 2025 | -1.74 Mn |
| Dec 31, 2024 | -1.75 Mn |
| Sep 30, 2024 | -11.86 Mn |
| Jun 30, 2024 | -1.49 Mn |
| Mar 31, 2024 | -1.42 Mn |
| Dec 31, 2023 | -1.67 Mn |
| Sep 30, 2023 | -803,000.00 |
| Jun 30, 2023 | -1.87 Mn |